S100B and Stroke: In ischemic stroke, high levels of S100B have been associated with the degree of systemic inflammation disregarding the size of the infarction (Michetti et al., 2012), therefore S100B has been proposed as a potential biomarker to predict recovery outcomes after stroke (Rahmati et al., 2020).